Interferon-β1a protects neurons against mitochondrial toxicity via modulation of STAT1 signaling: Electrophysiological evidence

作者: Massimiliano Di Filippo , Alessandro Tozzi , Michela Tantucci , Sara Arcangeli , Davide Chiasserini

DOI: 10.1016/J.NBD.2013.09.022

关键词:

摘要: Multiple sclerosis, one of the main causes non-traumatic neurological disability in young adults, is an inflammatory and neurodegenerative disorder central nervous system. Although pathogenesis neuroaxonal damage occurring during course disease still largely unknown, there accumulating evidence highlighting potential role mitochondria multiple sclerosis-associated neuronal degeneration. The aim present study was to investigate, by utilizing electrophysiological techniques brain striatal slices, protective effects interferon-β1a, most widely used medication for against acute dysfunction induced mitochondrial toxins. Interferon-β1a found exert a dose-dependent effect progressive loss field amplitude complex I inhibitor rotenone. also reduced generation rotenone-induced inward current spiny neurons. Conversely, interferon-β1a did not influence II 3-nitropropionic acid. inhibition be dependent on activation STAT1 signaling. endogenous dopamine depletion modulation p38 MAPK mTOR pathways interferon-β1a. During experimental autoimmune encephalomyelitis (EAE) rotenone toxicity enhanced but evident. These results support future studies investigating played specific intracellular signaling mediating link among inflammation, impairment degeneration sclerosis.

参考文章(39)
Susan Duty, Peter Jenner, Animal models of Parkinson's disease: a source of novel treatments and clues to the cause of the disease British Journal of Pharmacology. ,vol. 164, pp. 1357- 1391 ,(2011) , 10.1111/J.1476-5381.2011.01426.X
David A. Frank, Sudipta Mahajan, Jerome Ritz, Fludarabine-induced immunosuppression is associated with inhibition of STAT1 signaling Nature Medicine. ,vol. 5, pp. 444- 447 ,(1999) , 10.1038/7445
Massimiliano Di Filippo, Davide Chiasserini, Alessandro Tozzi, Barbara Picconi, Paolo Calabresi, Mitochondria and the link between neuroinflammation and neurodegeneration Journal of Alzheimer's Disease. ,vol. 20, pp. 369- 379 ,(2010) , 10.3233/JAD-2010-100543
Barbara Picconi, Diego Centonze, Kerstin Håkansson, Giorgio Bernardi, Paul Greengard, Gilberto Fisone, M. Angela Cenci, Paolo Calabresi, Loss of bidirectional striatal synaptic plasticity in L-DOPA-induced dyskinesia Nature Neuroscience. ,vol. 6, pp. 501- 506 ,(2003) , 10.1038/NN1040
Maarten E. Witte, Jeroen J.G. Geurts, Helga E. de Vries, Paul van der Valk, Jack van Horssen, Mitochondrial dysfunction: a potential link between neuroinflammation and neurodegeneration? Mitochondrion. ,vol. 10, pp. 411- 418 ,(2010) , 10.1016/J.MITO.2010.05.014
Lufen Chang, Michael Karin, Mammalian MAP kinase signalling cascades Nature. ,vol. 410, pp. 37- 40 ,(2001) , 10.1038/35065000
Massimiliano Di Filippo, Barbara Picconi, Cinzia Costa, Vincenza Bagetta, Michela Tantucci, Lucilla Parnetti, Paolo Calabresi, Pathways of neurodegeneration and experimental models of basal ganglia disorders: downstream effects of mitochondrial inhibition. European Journal of Pharmacology. ,vol. 545, pp. 65- 72 ,(2006) , 10.1016/J.EJPHAR.2006.06.024
Ranjan Dutta, Bruce D. Trapp, Mechanisms of neuronal dysfunction and degeneration in multiple sclerosis. Progress in Neurobiology. ,vol. 93, pp. 1- 12 ,(2011) , 10.1016/J.PNEUROBIO.2010.09.005
Susanne Beyer, Gergana Raether, Konstantin Stadler, Raimund Hoffrogge, Christian Scharf, Arndt Rolfs, Eilhard Mix, Ulf Strauss, Interferon-β modulates protein synthesis in the central nervous system Journal of Neuroimmunology. ,vol. 213, pp. 31- 38 ,(2009) , 10.1016/J.JNEUROIM.2009.06.004
Roseane Santos, Bianca Weinstock-Guttman, Miriam Tamaño-Blanco, Darlene Badgett, Robert Zivadinov, Theresa Justinger, Frederick Munschauer, Murali Ramanathan, Dynamics of interferon-β modulated mRNA biomarkers in multiple sclerosis patients with anti-interferon-β neutralizing antibodies Journal of Neuroimmunology. ,vol. 176, pp. 125- 133 ,(2006) , 10.1016/J.JNEUROIM.2006.03.019